HUP9801327A3 - Use of benzotiophene derivatives for production of medicaments inhibiting ovarian cancer - Google Patents

Use of benzotiophene derivatives for production of medicaments inhibiting ovarian cancer

Info

Publication number
HUP9801327A3
HUP9801327A3 HU9801327A HUP9801327A HUP9801327A3 HU P9801327 A3 HUP9801327 A3 HU P9801327A3 HU 9801327 A HU9801327 A HU 9801327A HU P9801327 A HUP9801327 A HU P9801327A HU P9801327 A3 HUP9801327 A3 HU P9801327A3
Authority
HU
Hungary
Prior art keywords
production
ovarian cancer
inhibiting ovarian
benzotiophene
derivatives
Prior art date
Application number
HU9801327A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of HUP9801327A2 publication Critical patent/HUP9801327A2/hu
Publication of HUP9801327A3 publication Critical patent/HUP9801327A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
HU9801327A 1995-02-28 1996-02-27 Use of benzotiophene derivatives for production of medicaments inhibiting ovarian cancer HUP9801327A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39595195A 1995-02-28 1995-02-28

Publications (2)

Publication Number Publication Date
HUP9801327A2 HUP9801327A2 (hu) 1999-06-28
HUP9801327A3 true HUP9801327A3 (en) 1999-10-28

Family

ID=23565226

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9801327A HUP9801327A3 (en) 1995-02-28 1996-02-27 Use of benzotiophene derivatives for production of medicaments inhibiting ovarian cancer

Country Status (13)

Country Link
EP (1) EP0729755A2 (enExample)
JP (1) JPH11501033A (enExample)
KR (1) KR19980702553A (enExample)
CN (1) CN1176600A (enExample)
AU (1) AU5028696A (enExample)
CA (1) CA2214080A1 (enExample)
EA (1) EA199700200A1 (enExample)
FI (1) FI973521A7 (enExample)
HU (1) HUP9801327A3 (enExample)
IL (1) IL117277A0 (enExample)
NO (1) NO973963L (enExample)
WO (1) WO1996026727A1 (enExample)
ZA (1) ZA961564B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5886025A (en) * 1997-03-06 1999-03-23 Baylor University Anti-mitotic agents which inhibit tubulin polymerization
AU781168B2 (en) * 2001-01-26 2005-05-12 Pfizer Products Inc. Method of treating certain cancers using an estrogen agonist/antagonist
FR2873692B1 (fr) * 2004-07-29 2006-12-01 Univ Claude Bernard Lyon COMPOSITIONS CONTENANT, EN ASSOCIATION AVEC UN AGENT ANTIMICROBIEN, UN COMPOSE THIOPHENIQUE OU BENZOTHIOPHENIQUE DE FORMULE(I)PRESENTANT UNE ACTIVITE INHIBITRICE DE POMPE NorA
CN103432141A (zh) * 2013-08-29 2013-12-11 南京大学 Chukrasone A在治疗卵巢癌药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
DE3590389T1 (de) * 1984-08-02 1986-08-28 Schering Corp., Kenilworth, N.J. Pharmazeutische Zusammensetzung für eine Kombinationstherapie hormon-abhängiger Cancer
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
CZ253694A3 (en) * 1993-10-15 1995-05-17 Lilly Co Eli Pharmaceutical preparation for treating resistant neoplasms
IL115582A0 (en) * 1994-10-14 1996-01-19 Lilly Co Eli Methods for treating resistant tumors

Also Published As

Publication number Publication date
EP0729755A3 (enExample) 1996-09-11
EA199700200A1 (ru) 1998-02-26
CN1176600A (zh) 1998-03-18
JPH11501033A (ja) 1999-01-26
FI973521L (fi) 1997-08-27
ZA961564B (en) 1997-08-27
AU5028696A (en) 1996-09-18
WO1996026727A1 (en) 1996-09-06
FI973521A0 (fi) 1997-08-27
FI973521A7 (fi) 1997-08-27
NO973963D0 (no) 1997-08-28
NO973963L (no) 1997-08-28
IL117277A0 (en) 1996-06-18
KR19980702553A (ko) 1998-07-15
MX9706520A (es) 1997-11-29
EP0729755A2 (en) 1996-09-04
CA2214080A1 (en) 1996-09-06
HUP9801327A2 (hu) 1999-06-28

Similar Documents

Publication Publication Date Title
IL125404A0 (en) 4-amino-pyrimidine derivatives medicaments containing these compounds their use and process for their production
HUP9801877A3 (en) Medicaments containing tetrahydrofuryl-sulphonamide-derivative as inhibitors of aspartyl-proteases
PL322277A1 (en) Derivatives of pyrazol-4-ylobenzoyl
AU4419193A (en) Synthesis of 1,4,7-triazacyclononane derivatives
IL144155A (en) Process for the synthesis of dioxolane derivatives
SI0773224T1 (en) Process for the selective synthesis of silylalkyl disulfides
HU9800291D0 (en) Use of amido-pirimidine derivatives for producing pharmaceutical compositions for inhibiting decrease of glucose-metabolismus
HUP9801532A3 (en) Use of benzimidazole derivatives for producing pharmaceutical compositions for inhibiting the growth of cancers
HUP9900905A3 (en) Use of vitamin d4 derivatives for treating cancer
HUP9700126A3 (en) 2-oxo- and 2-thio-1,2-dihydroquinolinyl-oxazotidinone derivatives and pharmaceutical compositions containing them, process for producing the compounds and intermediates of them
PL324451A1 (en) Derivatives of diphenylmethylenepiperidine
IL123095A0 (en) Pharmaceutical compositions containing fluconazole for inhibiting the growth of cancers
SG72692A1 (en) Prodrugs of paclitaxel derivatives
EP0501757A3 (en) Production of hydrocarbon derivatives
HUP0004227A3 (en) Direct ortho-metalation process for the synthesis of 5-(2-substituted-phenyl)-tetrazol derivatives
AU7056994A (en) Process for asymmetric total synthesis of camptothecin
GR3032600T3 (en) Process for the production of imidazo-benzodiazepine derivatives
HUP9904034A3 (en) New process for the preparation of phenylimidazolidine derivatives
IL117486A (en) Processes for the preparation of taxanes utilizing oxazolidine derivatives
IL117574A0 (en) Processes for the preparation of cyclobutanone derivatives
ZA96452B (en) Dematological use of vitamin d derivatives
HUP9901093A3 (en) Use of benzotiophene derivatives for production of pharmaceuticals inhibiting melanoma
PL310486A1 (en) Novel compounds, derivatives of genistein
HUP9903481A3 (en) Process for the preparation of 1-aryl-1-cyanocyclobutane derivatives
HUP9801829A3 (en) Use of benzotiophene derivatives for producing pharmaceutical compositions for inhibiting effects of il-6